Genesight
Payments companies reported to CMS as associated with Genesight. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Genesight, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Genesight
These are the largest totals companies reported as associated with Genesight. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ifeyinwa Stitt | Silver Spring, MD | Obstetrics & Gynecology | $2,800.00 |
| Elizabeth August | Ridgefield Park, NJ | Family Medicine | $2,000.00 |
| Alfredo Santillan Gomez | San Antonio, TX | Surgical Oncology | $1,700.00 |
| Royce Adkins | Nashville, TN | Obstetrics & Gynecology | $1,250.00 |
| Leah Adkins | Columbus, OH | Obstetrics & Gynecology | $1,200.00 |
| Gustavo Alva | Orange, CA | Psychiatry | $1,100.00 |
| Candace Westgate | Indianapolis, IN | Obstetrics & Gynecology | $1,050.00 |
| Mark Edney | Berlin, MD | Urology | $1,000.00 |
| Whitnee Brown | Hoover, AL | Psychiatric/Mental Health (Nurse Practitioner) | $600.00 |
| Jigar Patel | Shenandoah, TX | Gastroenterology (Internal Medicine) | $237.50 |
Prescribed Genesight?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.